The concept of prediabetes (and similar concepts of impaired fasting glucose and impaired glucose tolerance) formally emerged in the 1990s to better characterize the incremental pathophysiology leading to the eventual development of diabetes.1 It is defined by ranges of disordered glucose values between normal and diabetes (eg, hemoglobin A1c levels, 5.7%-6.4% [to convert to the proportion of total hemoglobin, multiply by 0.01]). We treat it as a risk factor for diabetes; in midlife, those with a hemoglobin A1c level of 6.0% to 6.5% have 20 times the risk of developing diabetes compared with those with a hemoglobin A1c level of 5.0%.2
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Lam K, Lee SJ. Prediabetes—A Risk Factor Twice Removed. JAMA Intern Med. 2021;181(4):520–521. doi:10.1001/jamainternmed.2020.8773
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: